3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
5008
Neoplasms
4199
Prostatic Neoplasms
2428
Carcinoma, Non-Small-Cell Lung
2265
Colorectal Neoplasms
2053
Lung Neoplasms
1706
Multiple Myeloma
1459
Lymphoma
1405
Leukemia, Myeloid, Acute
1382
Neoplasm Metastasis
1376
Melanoma
1270
Pancreatic Neoplasms
1200
Leukemia
1196
Ovarian Neoplasms
1193
Lymphoma, Non-Hodgkin
1132
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1091
Head and Neck Neoplasms
1056
Leukemia, Lymphocytic, Chronic, B-Cell
994
Lymphoma, Follicular
897
Colonic Neoplasms
896
Brain Neoplasms
877
Stomach Neoplasms
858
Recurrence
855
Carcinoma, Hepatocellular
846
Glioblastoma
842
Lymphoma, Large B-Cell, Diffuse
772
Rectal Neoplasms
759
Uterine Cervical Neoplasms
729
Carcinoma, Renal Cell
705
Hodgkin Disease
698
Interventions
abiraterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Interventional
×
Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
×
Clear all
NCT01780220
2022-05-19
CARLHA
UNICANCER
Phase 1/2
Completed
47 enrolled